Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics

被引:4
|
作者
Sarah, Allegra [1 ,2 ]
Dondi, Emma [1 ]
De Francia, Silvia [1 ]
机构
[1] Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Orbassano, TO, Italy
[2] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Clin Pharmacol Serv Franco Ghezzo, Reg Gonzole 10, I-10043 Turin, TO, Italy
关键词
Chemotherapy; Cancer; Precision Medicine; Personalized Treatment; IMATINIB;
D O I
10.1080/17425255.2023.2277758
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:733 / 739
页数:7
相关论文
共 50 条
  • [21] Tyrosine Kinase Inhibitors in Veterinary Medicine
    London, Cheryl A.
    TOPICS IN COMPANION ANIMAL MEDICINE, 2009, 24 (03) : 106 - 112
  • [22] Tyrosine Kinase Inhibitors: The First Decade
    Meetu Agrawal
    Ravin J. Garg
    Jorge Cortes
    Alfonso Quintás-Cardama
    Current Hematologic Malignancy Reports, 2010, 5 : 70 - 80
  • [23] Arrhythmic complications of tyrosine kinase inhibitors
    Fradley, Michael G.
    Pinilla-Ibarz, Javier
    FUTURE CARDIOLOGY, 2015, 11 (04) : 395 - 399
  • [24] Tyrosine kinase inhibitors in veterinary oncology
    Koltai Zsofia
    Vajdovich Peter
    Jakab Csaba
    Szabo Bernadett
    MAGYAR ALLATORVOSOK LAPJA, 2017, 139 (08) : 465 - 472
  • [25] Tyrosine kinase inhibitors in hematological malignancies
    Kosior, Kamila
    Lewandowska-Grygiel, Magdalena
    Giannopoulos, Krzysztof
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2011, 65 : 819 - 828
  • [26] Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: the possible role of ponatinib
    Breccia, Massimo
    Efficace, Fabio
    Iurlo, Alessandra
    Luciano, Luigiana
    Abruzzese, Elisabetta
    Gozzini, Antonella
    Pregno, Patrizia
    Tiribelli, Mario
    Rosti, Gianantonio
    Minotti, Giorgio
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (06) : 623 - 628
  • [27] The role of histone lysine demethylases in cancer cells' resistance to tyrosine kinase inhibitors
    White, Jasmine Cassar
    Pucci, Perla
    Crea, Francesco
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 326 - 334
  • [28] Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer
    Zamecnikova, Adriana
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (01) : 77 - 92
  • [29] First-generation tyrosine-kinase inhibitors: the role of combination therapy
    Guilhot, F.
    ONCOLOGIE, 2012, 14 (10-11) : 583 - 588